VIRITAC, created in 2007 (United States), from 18 sister brands and 2214 competing brands. VIRITAC is owned by Vertex Pharma, listed on the stock exchange of New York The sector of VIRITAC is Biotechnology.

VIRITAC is a brand of Vertex Pharma (VRTX) Share price

Share price and profitability of the share Vertex Pharma (VIRITAC)

Buy Vertex Pharma share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 417.32

Portfolio valuation
Vertex Pharma (VIRITAC) over 5 years* USD 945.78

Stock market history Vertex Pharma (VIRITAC)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more